Atrial Septal Defect (ASD) Clinical Trials

Find Atrial Septal Defect (ASD) Clinical Trials Near You

Precision Neuromuscular Management: Quantitative TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Pediatric Minimally Invasive Cardiac Surgery (A Prospective Observational Cohort Study)

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This prospective observational cohort study evaluates a precision neuromuscular management strategy in pediatric patients undergoing minimally invasive cardiac surgery (MICS). Integrating MICS with enhanced recovery after surgery (ERAS) pathways has transformed perioperative management of congenital heart disease by enabling earlier recovery and reducing dependence on intensive care resources. A key component of these fast-track protocols is early tracheal extubation, preferably in the operating room (OR). Successful OR extubation promotes rapid return to spontaneous ventilation, decreases ICU utilization, and reduces the respiratory and hemodynamic risks associated with prolonged postoperative mechanical ventilation. To address critical perioperative challenges, including improving recovery outcomes and optimizing resource utilization in low- and middle-income country (LMIC) children's hospitals, this study compares the clinical efficacy, safety, and resource outcomes of quantitative train-of-four (TOF)-guided sugammadex administration with actively monitored spontaneous recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 18
Healthy Volunteers: f
View:

• Age older than 2 years and up to 18 years at the time of surgery.

• Scheduled for elective minimally invasive cardiac surgery (MICS) via a right mid-axillary thoracotomy for the repair of simple congenital heart defects (e.g., Ventricular Septal Defect, Atrial Septal Defect).

• Surgery requiring the use of cardiopulmonary bypass (CPB).

• Deemed an appropriate clinical candidate for the institutional early-extubation (fast-track) pathway.

• Intraoperative neuromuscular blockade maintained using rocuronium.

• Continuous intraoperative quantitative train-of-four (TOF) monitoring applied and calibrated.

• Written informed consent provided by a parent or legal guardian

Locations
Other Locations
Viet Nam
Vietnam National Children's Hospital (VNCH)
RECRUITING
Hanoi
Contact Information
Primary
Nguyen Thi Thu Hang, Medical Doctor
hang.nguyen@nch.gov.vn
+84 96 215 82 85
Backup
Hung Nguyen, Professor
hung.nguyen@ucsf.edu
408-315-9801
Time Frame
Start Date: 2025-12-04
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 80
Treatments
TOF-Guided Sugammadex Cohort
Pediatric MICS patients whose attending anesthesiologist elected to administer sugammadex for NMB reversal, with the dose tailored to the precise depth of the neuromuscular block as measured by quantitative TOF monitoring.
Monitored Spontaneous Recovery Cohort
Pediatric MICS patients whose attending anesthesiologist elected to forego pharmacological NMB reversal based on quantitative TOF monitoring, allowing the patient to achieve extubation criteria through actively monitored spontaneous recovery.
Related Therapeutic Areas
Sponsors
Leads: Dr. Nguyen Thi Thu Hang

This content was sourced from clinicaltrials.gov